Richard Elliott - Concepedia

Author

Richard Elliott

Also Known As

R Elliott, R J R ELLIOTT, R. Elliott, R. J. Elliott, R. J. R. ELLIOTT, Richard Elliott, Richard J R Elliott, Richard J. Elliott, Richard J. R. Elliott, Richard J.R Elliott

Publications

3.3K

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research Breast Cancer Now Cancer Research UK Edinburgh Cancer Research Royal Marsden Hospital

About

Richard Elliott is an author at Institute of Cancer Research specializing in medicine, cell biology, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	1.8K
2	Engineering	5	5	235
3	Natural Sciences	3	3	360
4	Social Sciences	1	1	31
5	Behavioral Sciences	1	1	31

Richard Elliott

Publications

3.2K

Citations

H-Index

Page 1

	Year	Citations
Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer María Teresa Herrera-Abreu, Marta Palafox, Uzma Asghar, Cancer Research Pi3k InhibitorsBreast OncologyEstrogen ReceptorCancer BiologyTumor Biology	2016	742
BMN 673, a Novel and Highly Potent PARP1/2 Inhibitor for the Treatment of Human Cancers with DNA Repair Deficiency Yuqiao Shen, Farah Rehman, Ying Feng, Clinical Cancer Research	2013	477
A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor Nicholas C. Turner, Christopher J. Lord, Elizabeth Iorns, The EMBO Journal Parp InhibitorNatural SciencesGeneticsMolecular BiologyGene Regulation	2008	323
Identification of CDK10 as an Important Determinant of Resistance to Endocrine Therapy for Breast Cancer Elizabeth Iorns, Nicholas C. Turner, Richard Elliott, Cancer Cell Breast OncologyOncologyMedicineImportant DeterminantImmunology	2008	228
Inactivation of Effector Caspases through Nondegradative Polyubiquitylation Mark Ditzel, Meike Broemer, Tencho Tenev, Molecular Cell Functional ModificationSignal TransductionBiomedical ResearchEffector CaspasesBioconjugation	2008	130
Discovery of senolytics using machine learning Vanessa Smer-Barreto, Andrea Quintanilla, Richard Elliott, Nature Communications	2023	107
A high-throughput screen identifies PARP1/2 inhibitors as a potential therapy for ERCC1-deficient non-small cell lung cancer Sophie Postel‐Vinay, Ilirjana Bajrami, Luc Friboulet, Oncogene MedicinePathologyPotential TherapyBronchial NeoplasmCancer Genomics	2013	96
Regulation of the Wnt signalling component PAR1A by the Peutz–Jeghers syndrome kinase LKB1 James Spicer, Sydonia Rayter, Neville Young, Oncogene Transcriptional RegulationSignal TransductionCell RegulationSignaling PathwayMolecular Regulation	2003	95
A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D Sydonia Rayter, Richard Elliott, Jon Travers, Oncogene Signal TransductionMedicineApoptosisMechanism Of ActionCell Death	2007	84
Phase Diagram of a Ternary Mixture of Cholesterol and Saturated and Unsaturated Lipids Calculated from a Microscopic Model Richard Elliott, Igal Szleifer, M. Schick Physical Review Letters Lipid AnalysisLipid BiophysicsEngineeringBiochemistryTernary Mixture	2006	77

Page 1